YaelTobiHarrisMD

Diabetes, Lipid Metabolism

Associate Professor, Medicine, Hofstra North Shore-LIJ

Dr. Harris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
865 Northern Blvd
Ste 203
Great Neck, NY 11021
Phone+1 516-708-2540

Fax+1 516-708-2573

Zucker School of Medicine at Hofstra/NorthwellFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2010
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2002 - 2005
New York University School of MedicineClass of 2002

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

PubMed

Cancer beliefs and diet self-management among cancer survivors with comorbid diabetes.
Kimberly A Muellers, Chloe Soukas, Rebecca Zeidman, Karisma Pantaleon, Yael T Harris
Journal of Cancer Survivorship. 2024-06-01
3 citations
Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia.
Benjamin Cohen, Yael Tobi Harris, Rifka Schulman-Rosenbaum
Endocrine Practice. 2024-04-01
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis.
Matthew Verdone, Jonathan Bauman, Esben Iversen, Rifka Schulman-Rosenbaum, Anthony Antonacci
Diabetes Spectrum. 2024-01-01

Alzheimer’s Drug Being Studied as Way to Reduce Type 2 Diabetes and Heart Disease RiskJuly 20th, 2017
Should People Without Diabetes Use Glucose Monitors?August 4th, 2023